ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-28
DOI: 10.2147/ijn.s639904 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Hua Liu und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, H., Ma, Q., Fan, H., Zhang, D., & Ma, W. (2026). ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition. International Journal of Nanomedicine, Volume 21, 1-28. https://doi.org/10.2147/ijn.s639904
Vancouver
Liu H, Ma Q, Fan H, Zhang D, Ma W. ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition. International Journal of Nanomedicine. 2026;Volume 21:1-28. doi:10.2147/ijn.s639904
BibTeX
@article{Liu2026,
author = {Liu, Hua and Ma, Qingsong and Fan, Huiping and Zhang, Dong and Ma, Weiyuan},
title = {ROS-Responsive Diselenide-Bridged Dendritic Mesoporous Silica Nanoparticles Enhance Licochalcone D Delivery for Atopic Dermatitis Therapy Associated with Oxidative Stress Modulation and JAK2/STAT5 Inhibition},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--28},
doi = {10.2147/ijn.s639904}
}
EUVIMED